Oncogene - Table of Contents alert Volume 37 Issue 19

If you are unable to see the message below, click here to view.

Advertisement RNA-seq library prep in less than 5 hours! New CATS RNA-seq library preparation Start-to-finish library preparation in 5 hours 30 minutes hands-on time Innovative "CATS" technology for RNA library prep from 10 pg input Detects more transcripts than any other commercial method -- guaranteed.  Learn more. TABLE OF CONTENTS Volume 37, Issue 19 In this issue Review Article Article Also new AOP Review Article The path to metastatic mouse models of colorectal cancer Gabriele Romano, Sharmeen Chagani & Lawrence N. Kwong Oncogene 2018 37 :2481 - 2489; February 21, 2018; 10.1038/s41388-018-0155-x Abstract | Full Text Beyond molecular tumor heterogeneity: protein synthesis takes control Santiago Ramon y Cajal, Josep Castellvi, Stefan Hümmer, Vicente Peg, Jerry Pelletier et al. Oncogene 2018 37 :2490 - 2501; February 21, 2018; 10.1038/s41388-018-0152-0 Abstract | Full Text Article Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer Sherona R. Sirkisoon, Richard L. Carpenter, Tadas Rimkus, Ashley Anderson, Alexandria Harrison et al. Oncogene 2018 37 :2502 - 2514; February 16, 2018; 10.1038/s41388-018-0132-4 Abstract | Full Text Snail regulates BMP and TGFß pathways to control the differentiation status of glioma-initiating cells Laia Caja, Kalliopi Tzavlaki, Mahsa S. Dadras, E-Jean Tan, Gad Hatem et al. Oncogene 2018 37 :2515 - 2531; February 16, 2018; 10.1038/s41388-018-0136-0 Abstract | Full Text The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia Hao Wang, Ling Bei, Chirag A. Shah, Weiqi Huang, Leonidas C. Platanias et al. Oncogene 2018 37 :2532 - 2544; February 20, 2018; 10.1038/s41388-018-0131-5 Abstract | Full Text Elevated mitochondrial SLC25A29 in cancer modulates metabolic status by increasing mitochondria-derived nitric oxide Huiyuan Zhang, Qinyi Wang, Junzhong Gu, Le Yin, Shenghui Liang et al. Oncogene 2018 37 :2545 - 2558; February 20, 2018; 10.1038/s41388-018-0139-x Abstract | Full Text The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia Antonella Di Costanzo, Nunzio Del Gaudio, Lidio Conte, Carmela Dell'Aversana, Michiel Vermeulen et al. Oncogene 2018 37 :2559 - 2572; February 22, 2018; 10.1038/s41388-018-0143-1 Abstract | Full Text Alternative transcription of a shorter, non-anti-angiogenic thrombospondin-2 variant in cancer-associated blood vessels Filip Roudnicky, Sun Young Yoon, Susanna Poghosyan, Simon Schwager, Cedric Poyet et al. Oncogene 2018 37 :2573 - 2585; February 22, 2018; 10.1038/s41388-018-0129-z Abstract | Full Text c-Jun/AP-1 overexpression reprograms ERa signaling related to tamoxifen response in ERa-positive breast cancer Huan He, Indranil Sinha, Rongrong Fan, Lars-Arne Haldosen, Feifei Yan et al. Oncogene 2018 37 :2586 - 2600; February 22, 2018; 10.1038/s41388-018-0165-8 Abstract | Full Text ERK5 is activated by oncogenic BRAF and promotes melanoma growth Ignazia Tusa, Sinforosa Gagliardi, Alessandro Tubita, Silvia Pandolfi, Carmelo Urso et al. Oncogene 2018 37 :2601 - 2614; February 27, 2018; 10.1038/s41388-018-0164-9 Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.